Pharmaceuticals · Key players

Top Hepatitis B Treatment companies

The 5 key players our Hepatitis B Treatment report profiles, and other companies free public records show in this market.

Key players in Hepatitis B Treatment

In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.

Key players in the Hepatitis B Treatment market
#CompanyWebsiteOur reports
1 Gilead Sciences, Inc. gilead.com (opens in a new tab) 297 reports
2 GSK PLC gsk.com (opens in a new tab) 1,254 reports
3 Arbutus Biopharma — 33 reports
4 Vir Biotechnology — 33 reports
5 Roche roche.com (opens in a new tab) 1,485 reports

Also active in Hepatitis B Treatment

Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.

Also active in Hepatitis B Treatment, from free public records
CompanyWhere public records show them
Mylan N.V.
Laurus
Aurobindo Pharma
Ausper Biopharma Co., Ltd.
Hetero Laboratories
Hetero Laboratories Ltd V
Grand Theravac Life Sciences (Nanjing) Co., Ltd.
ViiV Healthcare
Apotex Inc
BrightGene Bio-Medical Technology Co., Ltd.
Fujian Akeylink Biotechnology Co., Ltd.
Macleods Pharmaceuticals

Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Source: Drugs@FDA, US approvals each company holds for medicines on the market whose FDA label lists this use. Retrieved 13 Nov 2026.

Source: WHO Prequalification, Vaccines, tests and medicines on the WHO prequalified lists that match this market. Retrieved 13 Nov 2026.

Top trial sponsors in Hepatitis B Treatment

Companies leading the most active studies found with this market's trial search, worldwide (key players included).

  1. Ausper Biopharma Co., Ltd. 12 active trials on ClinicalTrials.gov (opens in a new tab)
  2. GSK PLC 6 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Grand Theravac Life Sciences (Nanjing) Co., Ltd. 5 active trials on ClinicalTrials.gov (opens in a new tab)
  4. Fujian Akeylink Biotechnology Co., Ltd. 4 active trials on ClinicalTrials.gov (opens in a new tab)
  5. Xiamen Amoytop Biotech Co., Ltd. 3 active trials on ClinicalTrials.gov (opens in a new tab)
  6. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 3 active trials on ClinicalTrials.gov (opens in a new tab)
  7. AusperBio Therapeutics Inc. 3 active trials on ClinicalTrials.gov (opens in a new tab)
  8. Suzhou HepaThera Biotech Co., Ltd. 3 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Hepatitis B Treatment reports by place

All 33 places for Hepatitis B Treatment

Get the full Hepatitis B Treatment report

Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.

Buy the full report Request free sample

Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.